País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium alginate; Potassium bicarbonate
Forum Health Products Ltd
Sodium alginate; Potassium bicarbonate
100mg/1ml ; 20mg/1ml
Oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01010201; GTIN: 5000158065628 5000158063693
GAVISCON ADVANCE ANISEED SUSPENSION. Sodium alginate and potassium hydrogen carbonate. READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take this medicine carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • YOU MUST CONTACT A DOCTOR IF YOUR SYMPTOMS WORSEN OR DO NOT IMPROVE AFTER 7 DAYS. • If any of the side-effects gets serious, or if you notice any side-effect not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What is Gaviscon Advance and what is it used for? 2. Before taking this medicine. 3. How to take this medicine. 4. Possible side effects. 5. How to store this medicine. 6. Further information. 1. WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR? Gaviscon Advance belongs to a group of medicines called "reflux suppressants". This product forms a protective layer that floats on top of the stomach contents. This layer prevents reflux and keeps the stomach contents away from the lining of the food pipe to relieve the symptoms of heartburn and acid indigestion. It can also be used to relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle through a muscle wall), reflux oesophagitis (inflamed foodpipe) and symptoms of hoarseness and other voice disorders, sore throat and cough associated with reflux. It can also be taken to control heartburn symptoms which may occur when taking, or following withdrawal of, medication to reduce stomach acid such as Proton Pump Inhibitors (PPIs) or H2 Antagonists. 2. BEFORE TAKING THIS MEDICINE DO NOT TAKE GAVISCON ADVANCE: - If you know you are allergic (hypersensitive) to any of the ingredients in this product (see ‘Further Information’ for a full list of ingredients). TAKE SPECIAL CARE WITH GAVISCON ADVANCE: This medicine contains 57.85 mg sodium (main component of cooking/table salt) in each 5 Leia o documento completo
OBJECT 1 GAVISCON ADVANCE ANISEED ORAL SUSPENSION Summary of Product Characteristics Updated 11-Jan-2023 | Forum Health Products Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Gaviscon Advance Aniseed Suspension. 2. Qualitative and quantitative composition ACTIVE SUBSTANCES MG/10ML Sodium alginate 1000.0 Potassium bicarbonate 200.0 Excipient(s) with known effect: Methyl parahydroxybenzoate E218 (20 mg/ 5 ml) Propyl parahydroxybenzoate E216 (3 mg/ 5 ml). Sodium (57.85 mg (2.515 mmol)/ 5 ml) Potassium (39.06 mg/ 5 ml) Benzyl alcohol* (0.525 mg/ 5 ml) *present in the fennel flavour For full list of excipients, see section 6.1. 3. Pharmaceutical form Oral suspension. An off-white, viscous suspension. 4. Clinical particulars 4.1 Therapeutic indications Treatment of symptoms resulting from the reflux of acid, bile and pepsin into the oesophagus such as acid regurgitation, heartburn, indigestion (occurring due to the reflux of stomach contents), for instance, after gas Leia o documento completo